{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:01:36Z","timestamp":1783771296386,"version":"3.55.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2021,12,7]],"date-time":"2021-12-07T00:00:00Z","timestamp":1638835200000},"content-version":"vor","delay-in-days":153,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,18]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Sarcoidosis is a multi-systemic granulomatous disease of unknown origin. Recent research has focused upon the role of autoimmunity in its development and progression. This study aimed to determine and define the disturbance and distribution of T and B cell subsets in the alveolar and peripheral compartments. Thirteen patients were selected for the study [median age, interquartile range (IQR) = 57 years (48\u201359); 23% were male]. Twelve healthy controls [median age, IQR = 53 years (52\u201365); 16% male] were also enrolled into the study. Cellular and cytokine patterns were measured using the cytofluorimetric approach. Peripheral CD8 percentages were higher in sarcoidosis patients (SP) than healthy controls (HC) (p = 0.0293), while CD4 percentages were lower (p = 0.0305). SP showed low bronchoalveolar lavage (BAL) percentages of CD19 (p = 0.0004) and CD8 (p = 0.0035), while CD19+CD5+CD27\u2212 percentages were higher (p = 0.0213); the same was found for CD4 (p = 0.0396), follicular regulatory T cells (Treg) (p = 0.0078) and Treg (p\u00a0&amp;lt;\u00a00.0001) cells. Low T helper type 17 (Th17) percentages were observed in BAL (p = 0.0063) of SP. Peripheral CD4+ C-X-C chemokine receptor (CXCR)5+CD45RA\u2212) percentages and follicular T helper cells (Tfh)-like Th1 (Tfh1) percentages (p = 0.0493 and p = 0.0305, respectively) were higher in the SP than HC. Tfh1 percentages and Tfh-like Th2 percentages were lower in BAL than in peripheral blood (p = 0.0370 and p = 0.0078, respectively), while CD4+ C-X-C motif CXCR5+CD45RA\u2212 percentages were higher (p = 0.0011). This is the first study, to our knowledge, to demonstrate a link between an imbalance in circulating and alveolar Tfh cells, especially CCR4-, CXCR3- and CXCR5-expressing Tfh subsets in the development of sarcoidosis. These findings raise questions about the pathogenesis of sarcoidosis and may provide new directions for future clinical studies and treatment strategies.<\/jats:p>","DOI":"10.1111\/cei.13635","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T17:28:19Z","timestamp":1623259699000},"page":"406-416","source":"Crossref","is-referenced-by-count":23,"title":["Adaptive immune system in pulmonary sarcoidosis\u2014Comparison of peripheral and alveolar biomarkers"],"prefix":"10.1093","volume":"205","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2368-5722","authenticated-orcid":false,"given":"Miriana","family":"d'Alessandro","sequence":"first","affiliation":[{"name":"Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences & Neurosciences, Siena University Hospital, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bergantini","sequence":"additional","affiliation":[{"name":"Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences & Neurosciences, Siena University Hospital, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cameli","sequence":"additional","affiliation":[{"name":"Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences & Neurosciences, Siena University Hospital, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Mezzasalma","sequence":"additional","affiliation":[{"name":"Diagnostic and Interventional Bronchoscopy Unit, Cardio-Thoracic and Vascular Department, University Hospital of Siena (Azienda Ospedaliera Universitaria Senese, AOUS), Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa Metella","family":"Refini","sequence":"additional","affiliation":[{"name":"Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences & Neurosciences, Siena University Hospital, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pieroni","sequence":"additional","affiliation":[{"name":"Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences & Neurosciences, Siena University Hospital, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piersante","family":"Sestini","sequence":"additional","affiliation":[{"name":"Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences & Neurosciences, Siena University Hospital, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Bargagli","sequence":"additional","affiliation":[{"name":"Respiratory Diseases and Lung Transplantation, Department of Medical and Surgical Sciences & Neurosciences, Siena University Hospital, Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,7,7]]},"reference":[{"key":"2021121100021948900_cei13635-bib-0001","first-page":"15553","article-title":"New advances in the management of pulmonary sarcoidosis","volume":"22","author":"Culver","year":"2019","journal-title":"BMJ"},{"key":"2021121100021948900_cei13635-bib-0002","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","article-title":"Sarcoidosis","volume":"5","author":"Grunewald","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"2021121100021948900_cei13635-bib-0003","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1056\/NEJM198108203050804","article-title":"Pulmonary sarcoidosis: a disorder mediated by excess helper T-lymphocyte activity at sites of disease activity","volume":"305","author":"Hunninghake","year":"1981","journal-title":"N Engl J Med"},{"key":"2021121100021948900_cei13635-bib-0004","doi-asserted-by":"crossref","first-page":"e9088","DOI":"10.1371\/journal.pone.0009088","article-title":"Significant CD4, CD8, and CD19 lymphopenia in peripheral blood of sarcoidosis patients correlates with severe disease manifestations","volume":"5","author":"Sweiss","year":"2010","journal-title":"PLOS ONE"},{"key":"2021121100021948900_cei13635-bib-0005","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1136\/thx.2010.140319","article-title":"Sarcoidosis is a Th1\/Th17 multisystem disorder","volume":"66","author":"Facco","year":"2011","journal-title":"Thorax"},{"key":"2021121100021948900_cei13635-bib-0006","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1164\/rccm.201507-1499OC","article-title":"IFN-\u03b3-producing T-helper 17.1 cells are increased in sarcoidosis and are more prevalent than T-helper type 1 cells","volume":"193","author":"Ramstein","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"2021121100021948900_cei13635-bib-0007","doi-asserted-by":"crossref","first-page":"1701124","DOI":"10.1183\/13993003.01124-2017","article-title":"Increased T-helper 17.1 cells in sarcoidosis mediastinal lymph nodes","volume":"51","author":"Broos","year":"2018","journal-title":"Eur Respir J"},{"key":"2021121100021948900_cei13635-bib-0008","first-page":"125","article-title":"HLA and environmental interactions in sarcoidosis","volume":"25","author":"Rossman","year":"2008","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"2021121100021948900_cei13635-bib-0009","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1016\/j.chest.2017.11.030","article-title":"The pathogenesis of pulmonary sarcoidosis and implications for treatment","volume":"153","author":"Patterson","year":"2018","journal-title":"Chest"},{"key":"2021121100021948900_cei13635-bib-0010","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1165\/rcmb.2016-0037OC","article-title":"Programmed death-1 inhibition of phosphatidylinositol 3-kinase\/AKT\/mechanistic target of rapamycin signaling impairs sarcoidosis CD4+ T cell proliferation","volume":"56","author":"Celada","year":"2017","journal-title":"Am J Respir Cell Mol Biol"},{"key":"2021121100021948900_cei13635-bib-0011","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.rmed.2017.10.006","article-title":"Enhanced CD8+ cytolytic T cell responses in the peripheral circulation of patients with sarcoidosis and non-L\u00f6fgren's disease","volume":"138S","author":"Parasa","year":"2018","journal-title":"Respir Med"},{"key":"2021121100021948900_cei13635-bib-0012","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1183\/13993003.00092-2016","article-title":"Expanded lung T-bet+ROR\u03b3T+ CD4+ T-cells in sarcoidosis patients with a favourable disease phenotype","volume":"48","author":"Kaiser","year":"2016","journal-title":"Eur Respir J"},{"key":"2021121100021948900_cei13635-bib-0013","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/MCP.0000000000000498","article-title":"Role of imbalance between Th17 and regulatory T-cells in sarcoidosis","volume":"24","author":"Crouser","year":"2018","journal-title":"Curr Opin Pulm Med"},{"key":"2021121100021948900_cei13635-bib-0014","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1097\/00063198-200209000-00016","article-title":"T-lymphocytes and cytokines in sarcoidosis","volume":"8","author":"Agostini","year":"2002","journal-title":"Curr Opin Pulm Med"},{"key":"2021121100021948900_cei13635-bib-0015","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s10238-020-00608-5","article-title":"BAL biomarkers\u2019 panel for differential diagnosis of interstitial lung diseases","volume":"20","author":"d'Alessandro","year":"2020","journal-title":"Clin Exp Med"},{"key":"2021121100021948900_cei13635-bib-0016","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s10238-019-00578-3","article-title":"NK and NKT-like cells in granulomatous and fibrotic lung diseases","volume":"19","author":"Bergantini","year":"2019","journal-title":"Clin Exp Med"},{"key":"2021121100021948900_cei13635-bib-0017","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1128\/CVI.05118-11","article-title":"Disturbed homeostasis and multiple signaling defects in the peripheral blood B-cell compartment of patients with severe chronic sarcoidosis","volume":"18","author":"Lee","year":"2011","journal-title":"Clin Vaccine Immunol"},{"key":"2021121100021948900_cei13635-bib-0018","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1172\/JCI110036","article-title":"Mechanisms of hypergammaglobulinemia in pulmonary sarcoidosis. Site of increased antibody production and role of T lymphocytes","volume":"67","author":"Hunninghake","year":"1981","journal-title":"J Clin Invest"},{"key":"2021121100021948900_cei13635-bib-0019","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1164\/rccm.201206-1024OC","article-title":"Perigranuloma localization and abnormal maturation of B cells: emerging key players in sarcoidosis?","volume":"187","author":"Kamphuis","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"2021121100021948900_cei13635-bib-0020","doi-asserted-by":"crossref","first-page":"8431838","DOI":"10.1155\/2017\/8431838","article-title":"Increased circulating Th17 but decreased CD4+Foxp3+ Treg and CD19+CD1dhiCD5+ Breg subsets in new-onset Graves\u2019 disease","volume":"2017","author":"Qin","year":"2017","journal-title":"Biomed Res Int"},{"key":"2021121100021948900_cei13635-bib-0021","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1038\/s41598-020-57741-0","article-title":"Imbalance in B cell and T follicular helper cell subsets in pulmonary sarcoidosis","volume":"10","author":"Kudryavtsev","year":"2020","journal-title":"Sci Rep"},{"key":"2021121100021948900_cei13635-bib-0022","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.1007\/s10067-018-4183-2","article-title":"Significant elevation of the levels of B-cell activating factor (BAFF) in patients with sarcoidosis","volume":"37","author":"Ando","year":"2018","journal-title":"Clin Rheumatol"},{"key":"2021121100021948900_cei13635-bib-0023","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.3389\/fimmu.2018.01637","article-title":"T follicular helper cells in autoimmune disorders","volume":"9","author":"Gensous","year":"2018","journal-title":"Front Immunol"},{"key":"2021121100021948900_cei13635-bib-0024","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1034\/j.1399-3003.1999.14d02.x","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. Sarcoidosis Statement Committee. American Thoracic Society. European Respiratory Society. World Association for Sarcoidosis and Other Granulomatous Disorders","volume":"14","author":"Costabel","year":"1999","journal-title":"Eur Respir J"},{"key":"2021121100021948900_cei13635-bib-0025","first-page":"736","article-title":"Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999","volume":"160","author":"Statement on Sarcoidosis","year":"1999","journal-title":"Am J Respir Crit Care Med"},{"key":"2021121100021948900_cei13635-bib-0026","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","article-title":"Prognosis of intrathoracic sarcoidosis in England. A review of 136 cases after five years\u2019 observation","volume":"2","author":"Scadding","year":"1961","journal-title":"BMJ"},{"key":"2021121100021948900_cei13635-bib-0027","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/7651_2014_99","article-title":"Peripheral blood mononuclear cells: isolation, freezing, thawing, and culture","volume":"1304","author":"Riedhammer","year":"2016","journal-title":"Methods Mol Biol"},{"key":"2021121100021948900_cei13635-bib-0028","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1183\/09031936.93.03080937","article-title":"Clinical guidelines and indications for bronchoalveolar lavage (BAL): report of the European Society of Pneumology Task Group on BAL","volume":"3","author":"European Society of Pneumology","year":"1990","journal-title":"Eur Respir J"},{"key":"2021121100021948900_cei13635-bib-0029","doi-asserted-by":"crossref","first-page":"e13031","DOI":"10.1111\/sji.13031","article-title":"Regulatory T cell monitoring in severe eosinophilic asthma patients treated with mepolizumab","volume":"19","author":"Bergantini","year":"2021","journal-title":"Scand J Immunol"},{"key":"2021121100021948900_cei13635-bib-0030","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s10753-019-01157-0","article-title":"Regulatory T cells in severe persistent asthma in the era of monoclonal antibodies target therapies","volume":"43","author":"Bergantini","year":"2020","journal-title":"Inflammation"},{"key":"2021121100021948900_cei13635-bib-0031","doi-asserted-by":"crossref","first-page":"107525","DOI":"10.1016\/j.intimp.2021.107525","article-title":"Immunologic responses to antifibrotic treatment in IPF patients","volume":"11","author":"d'Alessandro","year":"2021","journal-title":"Int Immunopharmacol"},{"key":"2021121100021948900_cei13635-bib-0032","volume-title":"Human,Th1\/Th2\/Th17,Kit,RUO - 560484 | BD Biosciences\u00a0\u2013\u00a0US"},{"key":"2021121100021948900_cei13635-bib-0033","volume-title":"LEGENDplexTM Data Analysis"},{"key":"2021121100021948900_cei13635-bib-0034","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.mayocp.2016.04.012","article-title":"Epidemiology of sarcoidosis","volume":"91","author":"Reich","year":"2016","journal-title":"Mayo Clin Proc"},{"key":"2021121100021948900_cei13635-bib-0035","doi-asserted-by":"crossref","DOI":"10.7326\/0003-4819-156-9-201205010-01005","article-title":"Sarcoidosis","volume":"156","author":"O'Regan","year":"2012","journal-title":"Ann Intern Med"},{"key":"2021121100021948900_cei13635-bib-0036","doi-asserted-by":"crossref","first-page":"e451","DOI":"10.1016\/j.jfo.2018.10.002","article-title":"Sarcoidosis","volume":"41","author":"Salah","year":"2018","journal-title":"J Fr Ophtalmol"},{"key":"2021121100021948900_cei13635-bib-0037","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.mcna.2018.12.011","article-title":"Sarcoidosis","volume":"103","author":"Llanos","year":"2019","journal-title":"Med Clin North Am"},{"key":"2021121100021948900_cei13635-bib-0038","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1080\/17476348.2019.1655401","article-title":"New concepts in the pathogenesis of sarcoidosis","volume":"13","author":"Bennett","year":"2019","journal-title":"Expert Rev Respir Med"},{"key":"2021121100021948900_cei13635-bib-0039","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.3389\/fimmu.2018.02461","article-title":"Regulatory T Cells suppress effector t cell proliferation by limiting division destiny","volume":"9","author":"Dowling","year":"2018","journal-title":"Front Immunol"},{"key":"2021121100021948900_cei13635-bib-0040","first-page":"154","article-title":"Th17 and Treg cell levels in patients with sarcoidosis and their relation to disease activation","volume":"44","author":"Weng","year":"2015","journal-title":"Zhejiang Da Xue Xue Bao Yi Xue Ban"},{"key":"2021121100021948900_cei13635-bib-0041","doi-asserted-by":"crossref","first-page":"e0148207","DOI":"10.1371\/journal.pone.0148207","article-title":"The circulating Treg\/Th17 cell ratio is correlated with relapse and treatment response in pulmonary sarcoidosis patients after corticosteroid withdrawal","volume":"11","author":"Liu","year":"2016","journal-title":"PLOS ONE"},{"key":"2021121100021948900_cei13635-bib-0042","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1084\/jem.20050648","article-title":"The immune paradox of sarcoidosis and regulatory T cells","volume":"203","author":"Miyara","year":"2006","journal-title":"J Exp Med"},{"key":"2021121100021948900_cei13635-bib-0043","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1002\/art.1780310509","article-title":"B cells expressing CD5 are increased in Sj\u00f6gren's syndrome","volume":"31","author":"Dauphin\u00e9e","year":"1988","journal-title":"Arthritis Rheum"},{"key":"2021121100021948900_cei13635-bib-0044","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.jaci.2015.09.014","article-title":"In-depth characterization of CD24(high)CD38(high) transitional human B cells reveals different regulatory profiles","volume":"137","author":"Simon","year":"2016","journal-title":"J Allergy Clin Immunol"},{"key":"2021121100021948900_cei13635-bib-0045","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1146\/annurev-immunol-041015-055605","article-title":"Follicular helper T cells","volume":"20","author":"Vinuesa","year":"2016","journal-title":"Annu Rev Immunol"},{"key":"2021121100021948900_cei13635-bib-0046","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.immuni.2010.12.012","article-title":"Human blood CXCR5(+)CD4(+) T cells are counterparts of T follicular cells and contain specific subsets that differentially support antibody secretion","volume":"34","author":"Morita","year":"2011","journal-title":"Immunity"},{"key":"2021121100021948900_cei13635-bib-0047","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.3389\/fimmu.2017.01790","article-title":"Are follicular regulatory T cells involved in autoimmune diseases?","volume":"8","author":"Gong","year":"2017","journal-title":"Front Immunol"},{"key":"2021121100021948900_cei13635-bib-0048","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1038\/nm.2425","article-title":"Foxp3+ follicular regulatory T cells control the germinal center response","volume":"17","author":"Linterman","year":"2011","journal-title":"Nat Med"},{"key":"2021121100021948900_cei13635-bib-0049","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jdermsci.2020.02.002","article-title":"Exploring the imbalance of circulating follicular helper CD4+ T cells in sarcoidosis patients","volume":"97","author":"Ly","year":"2020","journal-title":"J Dermatol Sci"},{"key":"2021121100021948900_cei13635-bib-0050","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12865-015-0068-1","article-title":"CXCL13 antibody for the treatment of autoimmune disorders","volume":"12","author":"Klimatcheva","year":"2015","journal-title":"BMC Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cei.13635","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/cei.13635","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/205\/3\/406\/41591540\/cei13635.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/205\/3\/406\/41591540\/cei13635.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T18:27:59Z","timestamp":1699122479000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/205\/3\/406\/6431045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,7]]},"references-count":50,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,7,7]]},"published-print":{"date-parts":[[2021,8,18]]}},"URL":"https:\/\/doi.org\/10.1111\/cei.13635","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,9]]},"published":{"date-parts":[[2021,7,7]]}}}